Recent research shows that women who start the most common type of hormone therapy — estrogen plus progestin — soon after menopause have a significantly higher risk of breast cancer than those who take the hormones later or not at all. James Simon, M.D., clinical professor of Obstetrics and Gynecology in the School of Medicine and Health Sciences, says estrogen promotes the growth of almost everything, including undetectable tumors in the breasts.
Considering Hormone Replacement Therapy?
Latest News
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Monica M. Bertagnolli, MD, will be the keynote speaker for the 2026 GW MD Graduation Celebration and Diploma Ceremony on May 17, 2026, in Lisner Auditorium.
Sally Feng, a student in the Integrated Biomedical Sciences (IBS) PhD program at GW’s School of Medicine and Health Sciences (SMHS), recently earned a prestigious predoctoral fellowship award from the National Institutes of Health (NIH).
Francis Collins, MD, PhD, former director of the National Institutes of Health and former leader of the National Human Genome Research Institute, described the contrast between rapid scientific progress and the challenges posed by political polarization at the George Washington University’s GW Med…